STALEVO Drug Patent Profile
✉ Email this page to a colleague
When do Stalevo patents expire, and what generic alternatives are available?
Stalevo is a drug marketed by Orion Pharma and is included in one NDA.
The generic ingredient in STALEVO is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for STALEVO?
- What are the global sales for STALEVO?
- What is Average Wholesale Price for STALEVO?
Summary for STALEVO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for STALEVO |
| What excipients (inactive ingredients) are in STALEVO? | STALEVO excipients list |
| DailyMed Link: | STALEVO at DailyMed |
US Patents and Regulatory Information for STALEVO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orion Pharma | STALEVO 100 | carbidopa; entacapone; levodopa | TABLET;ORAL | 021485-002 | Jun 11, 2003 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Orion Pharma | STALEVO 200 | carbidopa; entacapone; levodopa | TABLET;ORAL | 021485-004 | Aug 2, 2007 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Orion Pharma | STALEVO 125 | carbidopa; entacapone; levodopa | TABLET;ORAL | 021485-006 | Aug 29, 2008 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Orion Pharma | STALEVO 150 | carbidopa; entacapone; levodopa | TABLET;ORAL | 021485-003 | Jun 11, 2003 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Orion Pharma | STALEVO 75 | carbidopa; entacapone; levodopa | TABLET;ORAL | 021485-005 | Aug 29, 2008 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
